Introducing the composite time trade-off: A test of feasibility and face validity

European Journal of Health Economics

Volumn 14, Issue SUPPL. 1, 2013, Pages

  Janssen, Bas M F ^a   Oppe, Mark ^b   Versteegh, Matthijs M ^c   Stolk, Elly A ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c ECORYS Netherlands   (Netherlands)

Author keywords

EQ 5D; Health state values; Health related quality of life; Time trade off

Indexed keywords

ARTICLE; COMPOSITE TIME TRADE OFF; FACE VALIDITY; FEASIBILITY STUDY; HEALTH STATUS; HEALTH STATUS INDICATOR; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; FEASIBILITY STUDIES; FEMALE; HEALTH STATUS; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TIME FACTORS; YOUNG ADULT;

EID: 84893026841     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-013-0503-2     Document Type: Article

References (25)

1. Herdman, M., Gudex, C., Lloyd, A., Janssen, M.F., Kind, P., Parkin, D., Bonsel, G.J., Badia, X.: Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual. Life Res. 20, 1727-1736 (2011)
2. Kim, S.H., Kim, H.J., Lee, S.I., et al.: Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Qual. Life Res. 21, 1065-1073 (2011)
3. Lee, C.F., Luo, N., Ng, R., Wong, N.S., Yap, Y.S., Lo, S.K., Chia, W.K., Yee, A., Krishna, L., Wong, C., Goh, C., Cheung, Y.B.: Comparison of the measurement properties between a short and generic instrument, the 5-level EuroQoL Group's 5-dimension (EQ-5D-5L) questionnaire, and a longer and disease-specific instrument, the Functional Assessment of Cancer Therapy-Breast (FACT-B), in Asian breast cancer patients. Qual. Life Res. (2012) (Epub ahead of print)
4. Janssen, M.F., Pickard, A.S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., Swinburn, P., Busschbach, J.J.: Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual. Life Res. (Forthcoming)
5. Tran, B.X., Ohinmaa, A., Nguyen, L.T.: Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients. Health. Qual. Life Outcomes. 10, 132 (2012)
6. van Hout, B., Janssen, M.F., Feng, Y.S., Kohlmann, T., Busschbach, J.J., Golicki, D., Lloyd, A., Scalone, L., Kind, P., Pickard, A.S.: Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 15, 708-715 (2012)
7. Devlin, N.J., Krabbe, P.F.M.: Editorial. Eur. J. Health Econ. (Forthcoming)
8. Szende, A., Oppe, M., Devlin, N. (eds.): EQ-5D value sets: inventory, comparative review and user guide. Springer, Dordrecht (2007)
9. Arnesen, T., Trommald, M.: Are QALYs based on time trade-off comparable?-A systematic review of TTO methodologies. Health Econ. 14, 39-53 (2005)
10. Arnesen, T., Trommald, M.: Roughly right or precisely wrong? Systematic review of quality-of-life weights elicited with the time trade-off method. J. Health Serv. Res Policy 9, 43-50 (2004)
11. Torrance, G.W.: Social preferences for health states: an empirical evaluation of three measurement techniques. Socioecon. Plan. Sci. 10, 129-136 (1976)
12. Lamers, L.M.: The transformation of utilities for health states worse than death: consequences for the estimation of EQ-5D value sets. Med. Care 45, 238-244 (2007)
13. Tilling, C., Devlin, N., Tsuchiya, A., Buckingham, K.: Protocols for time tradeoff valuations of health states worse than dead: a literature review. Med. Decis. Making 30, 610-619 (2010)
14. Devlin, N.J., Tsuchiya, A., Buckingham, K., Tilling, C.: A uniform time trade off method for states better and worse than dead: feasibility study of the 'lead-time' approach. Health Econ. 20, 348-361 (2011)
15. Devlin, N., Buckingham, K., Shah, K., Tsuchiya, A., Tilling, C., Wilkinson, G., van Hout, B.A.: comparison of alternative variants of the lead and lag time TTO. Health Econ. (Forthcoming)
16. Augustovki, F., Irazola, V., Devlin, N.J., Oppe, M.: Lead time versus lagtime TTO variants: does it make any difference? Eur. J. Health Econ. (Forthcoming)
17. Versteegh, M.M., Oppe, M., Attema,A.E., Devlin, N.J., Stolk, E.A.: Time to tweak the TTO: results from a comparison of alternative specifications of the TTO. Eur. J. Health Econ. (Forthcoming)
18. Oppe, M., Devlin, N., van Hout, B.A., Krabbe, P.F.M., de Charro, F.Th.: EuroQol Group's international protocol for the valuation of the EQ-5D-5L. (Forthcoming)
19. Mehrez, A., Gafni, A.: Quality-adjusted life years, utility theory, and healthy-years equivalents. Med. Decis. Making 9, 142-149 (1989)
20. Tsuchiya, A., Dolan, P.: The QALY model and individual preferences for health states and health profiles over time: a systematic review of the literature. Med. Decis. Making 25, 460-467 (2005)
21. Janssen, M.F., Birnie, E., Bonsel, G.J.: Feasibility and reliability of the annual profile method for deriving QALYs for short-term health conditions. Med. Decis. Making 28, 500-510 (2008)
22. Fishburn, P.C.: Independence in utility theory with whole product sets. Operations Res. 13, 28-45 (1965)
23. Johannesson, M., Jönsson, B., Karlsson, G.: Outcome measurement in economic evaluation. Health Econ. 5, 279-296 (1996)
24. Dolan, P.: Modelling valuations for EuroQol health states. Med. Care 35, 1095-1108 (1997)
25. Krabbe, P.F.M., Bonsel, G.J.: Sequence effects, health profiles, and the QALY model: in search of realistic modeling. Med. Decis. Making 18, 178-186 (1998)